BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3138 related articles for article (PubMed ID: 24125756)

  • 1. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway.
    Franklin M; Bu SY; Lerner MR; Lancaster EA; Bellmer D; Marlow D; Lightfoot SA; Arjmandi BH; Brackett DJ; Lucas EA; Smith BJ
    Bone; 2006 Dec; 39(6):1331-42. PubMed ID: 16890505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dried plum reverses bone loss in an osteopenic rat model of osteoporosis.
    Deyhim F; Stoecker BJ; Brusewitz GH; Devareddy L; Arjmandi BH
    Menopause; 2005; 12(6):755-62. PubMed ID: 16278620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):1-8. PubMed ID: 16637224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT; SamnegÄrd E; Cullen DM; Kimmel DB
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.
    Varela A; Chouinard L; Lesage E; Smith SY; Hattersley G
    J Bone Miner Res; 2017 Jan; 32(1):24-33. PubMed ID: 27748532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary supplementation with dried plum prevents ovariectomy-induced bone loss while modulating the immune response in C57BL/6J mice.
    Rendina E; Lim YF; Marlow D; Wang Y; Clarke SL; Kuvibidila S; Lucas EA; Smith BJ
    J Nutr Biochem; 2012 Jan; 23(1):60-8. PubMed ID: 21414765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
    McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
    Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.
    Shen CL; Zhu W; Gao W; Wang S; Chen L; Chyu MC
    Nutr Res; 2013 Aug; 33(8):668-76. PubMed ID: 23890357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats.
    Wang L; Orhii PB; Banu J; Kalu DN
    Mech Ageing Dev; 2001 Jan; 122(1):89-104. PubMed ID: 11163626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats.
    Wang L; Orhii PB; Banu J; Kalu DN
    Bone; 2001 Feb; 28(2):202-7. PubMed ID: 11182379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dried plum supplementation and intermittent PTH in restoring bone in osteopenic orchidectomized rats.
    Bu SY; Lucas EA; Franklin M; Marlow D; Brackett DJ; Boldrin EA; Devareddy L; Arjmandi BH; Smith BJ
    Osteoporos Int; 2007 Jul; 18(7):931-42. PubMed ID: 17554580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
    Kimmel DB; Bozzato RP; Kronis KA; Coble T; Sindrey D; Kwong P; Recker RR
    Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model.
    Ardawi MM; Badawoud MH; Hassan SM; Rouzi AA; Ardawi JMS; AlNosani NM; Qari MH; Mousa SA
    Bone; 2016 Feb; 83():127-140. PubMed ID: 26549245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats.
    Iwaniec UT; Moore K; Rivera MF; Myers SE; Vanegas SM; Wronski TJ
    Osteoporos Int; 2007 Mar; 18(3):351-62. PubMed ID: 17120182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 157.